MARY MCCOOL: Open Payments
NPI 1982482808 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,361 in 53 payments from 10 companies in 2025. Trend: 2023 $189 · 2024 $1,570 · 2025 $1,361
Food & beverage: $1,276Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $582 |
| ABBVIE INC. | 20 | $406 |
| Janssen Scientific Affairs, LLC | 2 | $93 |
| Aimmune Therapeutics, Inc. | 5 | $93 |
| Lilly USA, LLC | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Novo Nordisk Inc | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| CARDIVA MEDICAL, INC. | 1 | $17 |
Products named: TREMFYA, RINVOQ, ZENPEP, CREON, OMVOH, LINZESS, SKYRIZI, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
